Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 3H10] (IgG1) to Human VCAM1 / CD106
Human, Monkey, Dog
IHC - Paraffin, Immunofluorescence, Western blot
Mouse Monoclonal [clone 1.G11B1] (IgG1) to Human VCAM1 / CD106
IHC, Western blot, Flow Cytometry, ELISA, Functional Assay
Human VCAM1 / CD106
Human (tested or 100% immunogen sequence identity)
IgG1 Monoclonal [1.G11B1]
Protein A purified
Specificity and Use
VCAM1 / CD106 antibody was raised against human endothelial cells.
VCAM-1 molecule (CD106) which is involved with leukocyte adhesion.
Function: Binds to an epitope located within the first three n-terminal loops of CD106. This mAb blocks lymphocyte and eosinophil adhesion to CD106. It has been reported to work in IHC (frozen section) and Western blot.
50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 0.5 mg/ml Gentamicin sulfate
Vascular cell adhesion molecule 1, VCAM-1, is a surface glycoprotein expressed by cytokine-activated endothelium that mediates the adhesion of monocytes and lymphocytes. VCAM-1 and integrin alpha-4-beta-1 facilitate a critical cell-cell adhesion event required for survival of endothelial and mural cells during vascularization. Studies of heart development have shown that deficiencies of VCAM and in alpha-4 integrin also result in epicardial dissolution and subsequent myocardial thinning.